Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: AstraZeneca UK Limited., 600 Capability Green, Luton, LU1 3LU, UK
Tenoret 50 mg/12.5 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. White, round biconvex, film-coated, tablets which are intagliated with 50 12.5 on one face and bisected on the reverse face. The score line is not intended for breaking the tablet. |
Atenolol 50 mg.
Chlortalidone 12.5 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Atenolol |
Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects. |
|
| Chlortalidone |
Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action. |
| List of Excipients |
|---|
|
Magnesium carbonate |
Blister packs of 28 tablets contained in a carton.
AstraZeneca UK Limited., 600 Capability Green, Luton, LU1 3LU, UK
PL 17901/0048
Date of first authorisation: 01 June 2000
Date of latest renewal: 09 February 2005
| Drug | Countries | |
|---|---|---|
| TENORET | Hong Kong, Nigeria, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
